Nov 3, 2008

Oncolytics Biotech Inc. Announces Clinical Update Conference Call

Nov 3, 2008

Oncolytics Biotech Inc. Collaborators Present Positive Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting

Nov 3, 2008

Oncolytics Biotech Inc. Collaborators Present Positive Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting

Oct 23, 2008

Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting

Oct 23, 2008

Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting

Oct 23, 2008

Oncolytics Biotech Inc. Collaborators Present Reovirus and Melanoma Research at EORTC-NCI-AACR Symposium

Oct 22, 2008

Oncolytics Biotech Inc. Collaborators to Present Preclinical Combination REOLYSIN(R) and Cisplatin Research at EORTC-NCI-AACR Annual Meeting

Oct 21, 2008

Media Advisory - Oncolytics Biotech Inc. to Present at BIO Investor Forum 2008

Oct 9, 2008

Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe

Oct 8, 2008

Oncolytics Biotech Inc. Completes Initial Scale Up of Manufacturing Process for REOLYSIN(R) to Commercial Scale